搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
57 分钟
New robotic probe speeds up lung cancer diagnoses
A new state-of-the-art robotic probe is helping to speed up the diagnosis and treatment of lung cancer. Doctors at ...
7 小时
'Don’t give up': Beating lung cancer one step at a time
Over 900 people walked 1.5 miles through the zoo, which began with a ribbon-cutting and loud cheers from the crowd.
1 天
Incurable lung cancer could be defeated with breakthrough NHS treatment
Incurable lung cancer could soon become treatable, according to experts conducting a world-first trial on the NHS.
2 天
A 37-year-old nurse got unusually short of breath on a hike. She had stage 4 lung cancer.
Lung cancer is rare in people under 45, but rates are rising in non-smokers, particularly women. Tiffany Job was shocked to ...
2 天
These early signs of lung cancer are often missed, oncologists say
The statistics are grim, but there’s a reason why lung cancer often progresses past the point where it’s treatable: Early ...
2 天
2024 CSCO丨真实世界数据证实,曲拉西利可安全、有效改善 ES-SCLC 患者 ...
目前,化疗仍是 ES-SCLC 治疗的重要组成部分,但化疗导致的骨髓抑制(CIM)会严重影响患者用药依从性和预后,且现有的干预措施主要为对症治疗,存在局限性。为探索在真实世界环境中,预防性使用曲拉西利对我国 ES-SCLC ...
19 小时
Access to a GP can make all the difference in surviving lung cancer—and that is a problem ...
Surviving lung cancer in Aotearoa New Zealand could depend on whether you can access a GP—raising questions about equity in ...
3 天
ALK圆桌会丨CROWN试验引领ALK阳性NSCLC“临床治愈”,3+X全程管理剑指更 ...
间变性淋巴瘤激酶(anaplastic lymphoma kinase, ...
2 天
on MSN
Medical Breakthrough: 1st lung cancer vaccine BNT116 clinical trials launched, vaccine ...
BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.
腾讯网
4 天
癌症筛查有新招!河南省肿瘤医院4项成果亮相全球盛会!
近日,备受全球瞩目的肿瘤领域顶级国际盛会——2024世界癌症大会(World Cancer Congress)在瑞士日内瓦举行。
来自MSN
37 分钟
9 Foods That May Help Reduce Your Risk of Cancer
Cancer is a group of diseases characterized by the uncontrolled growth and spread of cells. There are hundreds of types of cancers, each named for what area of the body they affect. Some of the most ...
1 天
任胜祥教授:HER2 变异 NSCLC 领域捷报频传,德曲妥珠单抗带来治疗新 ...
任胜祥教授指出,德曲妥珠单抗作为肺癌领域首个获批的 HER2 靶向药物,其疗效已在系列研究中得到证实。DESTINY-Lung01 研究率先证实了德曲妥珠单抗(6.4 mg/kg)在经治 HER2 突变 NSCLC 患者中具有强大的抗肿瘤活性[6]。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈